A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Var2 Pharmaceuticals
Celgene
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc